Riskpilot← Back to searchSign inGet full accessOptomed Oyj
OYJActiveY-tunnus 1936446-1Yrttipellontie 1Retail sale of medical and orthopaedic goods · NACE 4774Est. 2004112 employees
Revenue 2024
EUR 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
EUR -3
-101% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR 0 | — |
| Net profit | EUR -3 | -101% |
| Total assets | EUR 0 | — |
| Equity | EUR 35,8M | — |
| Employees | 112 | — |
Legal name
Optomed Oyj
Y-tunnus number
1936446-1
Legal form
Julkinen osakeyhtiö
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
20. joulukuuta 2004
Share capital
EUR 80 000
Employees
112 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääketieteellisten ja terveydenhuollon laitteiden sekä ohjelmistojen sekä niihin liittyvien palveluiden kehitys, myynti, markkinointi, alihankinta, koulutus, konsultointi, projektityö, jälleenmyynti sekä niihin liittyvä ylläpito. Yhtiö voi omistaa ja hallita kiinteistöjä, osakkeita, osuuksia ja muita arvopapereita sekä käydä niillä kauppaa.
Address
Yrttipellontie 1
Phone
+3580207413380
Email
info@optomed.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 229 | 5 561 | 5 150 | — | 0 |
| Staff expenses | −2 849 | −3 390 | −3 502 | −0 | −0 |
| EBITDA | −2 369 | −1 970 | −2 165 | — | 0 |
| Depreciation & amort. | −1 247 | −1 741 | −2 203 | −0 | −0 |
| EBIT | −3 616 | −3 712 | −4 368 | 0 | — |
| Net financials | −226 | 22 | −967 | — | 0 |
| Profit before tax | −2 143 | −2 208 | −3 548 | — | −0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 143 | −2 208 | −3 548 | 0 | −0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 33 221 | 33 261 | 37 604 | 0 | 0 |
| Equity | 25 405 | 24 252 | 29 757 | 0 | 35 824 |
| Long-term debt | 6 196 | 6 250 | 5 328 | 0 | 1 310 |
| Short-term debt | 1 620 | 2 759 | 2 519 | 0 | 2 553 |
| Total debt | 7 816 | 9 009 | 7 847 | 0 | 3 862 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
3582437400.0%
This company
38.2%
Market median
+9378108277% vs market
20202024
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
-300.0%
This company
8.1%
Market median
-3804% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MJ Confidential Clerk | Confidential Clerk | 2019 |
JH Chief Executive Officer | Chief Executive Officer | 2023 |
SL Confidential Clerk | Confidential Clerk | 2019 |
LS Confidential Clerk | Confidential Clerk | 2016 |
| Former (7) | ||
SH Chief Executive Officer | Chief Executive Officer | 2006 – 2023 |
TJ | Audit | 2016 – 2023 |
LG Confidential Clerk | Confidential Clerk | 2019 – 2022 |
NK Confidential Clerk | Confidential Clerk | 2019 – 2022 |
ML Confidential Clerk | Confidential Clerk | 2016 – 2019 |
JM Confidential Clerk | Confidential Clerk | 2016 – 2019 |
KZ Deputy Member | Deputy Member | 2018 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (7) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Chairperson | 2018 | |
| Board of Directors | 2025 | |
| Former (10) | ||
| Board of Directors | 2022 – 2023 | |
JW | Board of Directors | 2018 – 2021 |
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2019 – 2020 | |
| Board of Directors | 2018 – 2020 | |
XG | Board of Directors | 2021 – 2022 |
| Board of Directors | 2019 – 2020 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2018 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Optomed Oyj (this company)
Optomed China Ltd, KiinaOptomed Hong Kong Limited, KiinaOptomed USA Inc., YhdysvallatBoard members of Optomed Oyj also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Seppo Henrik Kopsala | Chief Executive Officer | 0 companies |
| Markku Juhani Myllylä | Confidential Clerk | 0 companies |
| Tapio Johannes Raappana | Audit | 0 companies |
| Lars Göran Lindqvist | Confidential Clerk | 0 companies |
| Niina Katriina Huikuri | Confidential Clerk | 0 companies |
| Minna Liisa Korhonen | Confidential Clerk | 0 companies |
| Juho-Pekka Himberg | Chief Executive Officer | 0 companies |
| Sakari Lauri Knuutti | Confidential Clerk | 0 companies |
| Laura Susanna Piila | Confidential Clerk | 0 companies |
| Jyri Markus Leskelä | Confidential Clerk | 0 companies |
| Ke Zhang | Deputy Member | 0 companies |
| Xiaojie Duan | Board of Directors | 0 companies |
| Jun Wu | Board of Directors | 0 companies |
| Abbas Sotoudeh | Board of Directors | 0 companies |
| Lee Ty Ho | Board of Directors | 0 companies |
| Jens Stefan Umehag | Board of Directors | 0 companies |
| Reijo Einari Tauriainen | Board of Directors | 0 companies |
| Seppo Olavi Mäkinen | Board of Directors | 0 companies |
| Lars Anders Johannes Torstensson | Board of Directors | 0 companies |
| Catherine Anne Calarco | Board of Directors | 0 companies |
| Xisi Guo | Board of Directors | 0 companies |
| Sameer Badlani | Board of Directors | 0 companies |
| Matthew Hallam | Board of Directors | 0 companies |
| Anna Magdalena Tenstam | Board of Directors | 0 companies |
| Petri Paavali Salonen | Chairperson | 0 companies |
| Leana Sheryle Wen | Board of Directors | 0 companies |
| Roy Stoner | Board of Directors | 0 companies |
| Ingo Hans Ramesohl | Board of Directors | 0 companies |